Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Cavazzoni Andrea, Alfieri, Cretella Daniele, Saccani Francesca, Ampollini Luca, Galetti Maricla, Quaini Federico, Graiani Gallia, Madeddu Denise, Mozzoni Paola, Galvani Elena, La, Bonelli Mara, Fumarola Claudia, Mutti Antonio, Carbognani Paolo, Tiseo Marcello, Barocelli Elisabetta, Petronini, Ardizzoni Andrea